Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 EPIDEMIOLOGY MODELING
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER'S 5 FORCES
4.2 PESTEL ANALYSIS
5 EPIDEMIOLOGY
5.1 INCIDENCE
5.2 TREATMENT RATE
5.3 MORTALITY RATE
5.4 PATEINT TREATMENT SUCCESS RATES
6 INDUSTRY INSIGHTS
6.1 KEY PRICING STRATEGIES
6.2 INTERVIEWS WITH NEUROLOGISTS
6.3 INTERVIEWS WITH PSYCHOLOGIST
6.4 INTERVIEWS WITH NEURO RESEARCH CENTERS
6.5 OTHER KOL SNAPSHOTS
6.6 REGULATORY SCENARIO
7 GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR MARKET, BY TYPE
7.1 OVERVIEW
7.2 REPETITIVE TRANSCRANIAL MAGNITIC STIMULATOR (RTMS)
7.2.1 MARKET VALUE (USD MN)
7.2.2 MARKET VOLUME (UNITS)
7.2.3 AVERAGE SELLING PRICE (USD)
7.3 DEEP TRANSCRANIAL MAGNETIC STIMULATION (DTMS)
7.3.1 MARKET VALUE (USD MN)
7.3.2 MARKET VOLUME (UNITS)
7.3.3 AVERAGE SELLING PRICE (USD)
7.4 OTHERS
8 GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 DEPRESSION
8.2.1 REPETITIVE TRANSCRANIAL MAGNITIC STIMULATOR (RTMS)
8.2.2 DEEP TRANSCRANIAL MAGNETIC STIMULATION (DTMS)
8.3 UNIPOLAR & BIPOLAR DISORDERS
8.3.1 REPETITIVE TRANSCRANIAL MAGNITIC STIMULATOR (RTMS)
8.3.2 DEEP TRANSCRANIAL MAGNETIC STIMULATION (DTMS)
8.4 EPILEPSY
8.4.1 REPETITIVE TRANSCRANIAL MAGNITIC STIMULATOR (RTMS)
8.4.2 DEEP TRANSCRANIAL MAGNETIC STIMULATION (DTMS)
8.5 PARKINSON’S DISEASE
8.5.1 REPETITIVE TRANSCRANIAL MAGNITIC STIMULATOR (RTMS)
8.5.2 DEEP TRANSCRANIAL MAGNETIC STIMULATION (DTMS)
8.6 ALZHEIMER’S DISEASE
8.6.1 REPETITIVE TRANSCRANIAL MAGNITIC STIMULATOR (RTMS)
8.6.2 DEEP TRANSCRANIAL MAGNETIC STIMULATION (DTMS)
8.7 OTHERS
9 GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITAL
9.3 CLINICS
9.4 RADIOLOGY CENTERS
9.5 OTHERS
10 GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR MARKET, BY GEOGRAPHY
10.1 GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.2.3 MEXICO
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 U.K.
10.3.4 HUNGARY
10.3.5 LITHUANIA
10.3.6 AUSTRIA
10.3.7 IRELAND
10.3.8 NORWAY
10.3.9 POLAND
10.3.10 ITALY
10.3.11 SPAIN
10.3.12 RUSSIA
10.3.13 TURKEY
10.3.14 NETHERLANDS
10.3.15 SWITZERLAND
10.3.16 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 SOUTH KOREA
10.4.4 INDIA
10.4.5 AUSTRALIA
10.4.6 SINGAPORE
10.4.7 THAILAND
10.4.8 MALAYSIA
10.4.9 INDONESIA
10.4.10 PHILIPPINES
10.4.11 VIETNAM
10.4.12 REST OF ASIA-PACIFIC
10.5 SOUTH AMERICA
10.5.1 BRAZIL
10.5.2 ARGENTINA
10.5.3 PERU
10.5.4 REST OF SOUTH AMERICA
10.6 MIDDLE EAST AND AFRICA
10.6.1 SOUTH AFRICA
10.6.2 GLOBAL
10.6.3 UAE
10.6.4 EGYPT
10.6.5 KUWAIT
10.6.6 ISRAEL
10.6.7 REST OF MIDDLE EAST AND AFRICA
10.7 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
11 GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR MARKET, SWOT AND DBMR ANALYSIS
12 GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: GLOBAL
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
12.3 COMPANY SHARE ANALYSIS: EUROPE
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
12.5 MERGERS & ACQUISITIONS
12.6 NEW PRODUCT DEVELOPMENT & APPROVALS
12.7 EXPANSIONS
12.8 REGULATORY CHANGES
12.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
13 GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR MARKET, SWOT AND DBMR ANALYSIS
14 GLOBAL TRANSCRANIAL MAGNETIC STIMULATOR MARKET, COMPANY PROFILE
14.1 BRAINSWAY
14.1.1 COMPANY OVERVIEW
14.1.2 REVENUE ANALYSIS
14.1.3 GEOGRAPHIC PRESENCE
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 NEURONETICS
14.2.1 COMPANY OVERVIEW
14.2.2 REVENUE ANALYSIS
14.2.3 GEOGRAPHIC PRESENCE
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 NEUROSOFT
14.3.1 COMPANY OVERVIEW
14.3.2 REVENUE ANALYSIS
14.3.3 GEOGRAPHIC PRESENCE
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 GREENBROOK TMS NEUROHEALTH CENTERS.
14.4.1 COMPANY OVERVIEW
14.4.2 REVENUE ANALYSIS
14.4.3 GEOGRAPHIC PRESENCE
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 MAG & MORE
14.5.1 COMPANY OVERVIEW
14.5.2 REVENUE ANALYSIS
14.5.3 GEOGRAPHIC PRESENCE
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 MAGSTIM
14.6.1 COMPANY OVERVIEW
14.6.2 REVENUE ANALYSIS
14.6.3 GEOGRAPHIC PRESENCE
14.6.4 PRODUCT PORTFOLIO
14.6.5 RECENT DEVELOPMENTS
14.7 MAGVENTURE, INC.
14.7.1 COMPANY OVERVIEW
14.7.2 REVENUE ANALYSIS
14.7.3 GEOGRAPHIC PRESENCE
14.7.4 PRODUCT PORTFOLIO
14.7.5 RECENT DEVELOPMENTS
14.8 NEXSTIM PLC
14.8.1 COMPANY OVERVIEW
14.8.2 REVENUE ANALYSIS
14.8.3 GEOGRAPHIC PRESENCE
14.8.4 PRODUCT PORTFOLIO
14.8.5 RECENT DEVELOPMENTS
14.9 TMS NEUROSOLUTIONS
14.9.1 COMPANY OVERVIEW
14.9.2 REVENUE ANALYSIS
14.9.3 GEOGRAPHIC PRESENCE
14.9.4 PRODUCT PORTFOLIO
14.9.5 RECENT DEVELOPMENTS
14.1 ENEURA INC.
14.10.1 COMPANY OVERVIEW
14.10.2 REVENUE ANALYSIS
14.10.3 GEOGRAPHIC PRESENCE
14.10.4 PRODUCT PORTFOLIO
14.10.5 RECENT DEVELOPMENTS
14.11 YIRUIDE
14.11.1 COMPANY OVERVIEW
14.11.2 REVENUE ANALYSIS
14.11.3 GEOGRAPHIC PRESENCE
14.11.4 PRODUCT PORTFOLIO
14.11.5 RECENT DEVELOPMENTS
14.12 REMED
14.12.1 COMPANY OVERVIEW
14.12.2 REVENUE ANALYSIS
14.12.3 GEOGRAPHIC PRESENCE
14.12.4 PRODUCT PORTFOLIO
14.12.5 RECENT DEVELOPMENTS
14.13 DR. LANGER MEDICAL
14.13.1 COMPANY OVERVIEW
14.13.2 REVENUE ANALYSIS
14.13.3 GEOGRAPHIC PRESENCE
14.13.4 PRODUCT PORTFOLIO
14.13.5 RECENT DEVELOPMENTS
14.14 EB NEURO
14.14.1 COMPANY OVERVIEW
14.14.2 REVENUE ANALYSIS
14.14.3 GEOGRAPHIC PRESENCE
14.14.4 PRODUCT PORTFOLIO
14.14.5 RECENT DEVELOPMENTS
14.15 KEJIAN
14.15.1 COMPANY OVERVIEW
14.15.2 REVENUE ANALYSIS
14.15.3 GEOGRAPHIC PRESENCE
14.15.4 PRODUCT PORTFOLIO
14.15.5 RECENT DEVELOPMENTS
14.16 BRAINBOX
14.16.1 COMPANY OVERVIEW
14.16.2 REVENUE ANALYSIS
14.16.3 GEOGRAPHIC PRESENCE
14.16.4 PRODUCT PORTFOLIO
14.16.5 RECENT DEVELOPMENTS
14.17 AXILUM ROBOTICS
14.17.1 COMPANY OVERVIEW
14.17.2 REVENUE ANALYSIS
14.17.3 GEOGRAPHIC PRESENCE
14.17.4 PRODUCT PORTFOLIO
14.17.5 RECENT DEVELOPMENTS
14.18 NOBBOT
14.18.1 COMPANY OVERVIEW
14.18.2 REVENUE ANALYSIS
14.18.3 GEOGRAPHIC PRESENCE
14.18.4 PRODUCT PORTFOLIO
14.18.5 RECENT DEVELOPMENTS
14.19 AEGEA
14.19.1 COMPANY OVERVIEW
14.19.2 REVENUE ANALYSIS
14.19.3 GEOGRAPHIC PRESENCE
14.19.4 PRODUCT PORTFOLIO
14.19.5 RECENT DEVELOPMENTS
14.2 WUHAN YIRUIDE MEDICAL EQUIPMENT NEW TECHNOLOGY CO., LTD.
14.20.1 COMPANY OVERVIEW
14.20.2 REVENUE ANALYSIS
14.20.3 GEOGRAPHIC PRESENCE
14.20.4 PRODUCT PORTFOLIO
14.20.5 RECENT DEVELOPMENTS
14.21 CHANGZHOU SIYA MEDICAL INSTRUMENTS CO., LTD.
14.21.1 COMPANY OVERVIEW
14.21.2 REVENUE ANALYSIS
14.21.3 GEOGRAPHIC PRESENCE
14.21.4 PRODUCT PORTFOLIO
14.21.5 RECENT DEVELOPMENTS
14.22 KOMACHINE
14.22.1 COMPANY OVERVIEW
14.22.2 REVENUE ANALYSIS
14.22.3 GEOGRAPHIC PRESENCE
14.22.4 PRODUCT PORTFOLIO
14.22.5 RECENT DEVELOPMENTS
14.23 BECKMAN COULTER, INC
14.23.1 COMPANY OVERVIEW
14.23.2 REVENUE ANALYSIS
14.23.3 GEOGRAPHIC PRESENCE
14.23.4 PRODUCT PORTFOLIO
14.23.5 RECENT DEVELOPMENTS
15 CONCLUSION
16 QUESTIONNAIRE
17 ABOUT DATA BRIDGE MARKET RESEARCH
